January 25, 2023CorporateTerumo and Siemens Healthineers India collaborate to strengthen cardiac care in India
January 18, 2023CorporateFirst Patient Treated and Enrolled in Terumo Medical Corporation’s Osprey Iliac IDE Clinical TrialTrial aims to assure Terumo’s Misago® RX Self-expanding Peripheral Stent is safe and effective
Site Map Show — Site Map Hide — Site Map What’s new News Press Inquiries About Terumo Dear Stakeholders Who We Are Corporate Governance Compliance Regulations and Standards Procurement Activity At a Glance Terumo Group Identity Leadership Team History TERUMO’s Purpose Terumo's Response to COVID-19 Business Overview TIS Division (Terumo Interventional Systems) Neurovascular Division (MicroVention) Cardiovascular Division (Terumo Cardiovascular)/ HeartSheet Division Vascular Graft Division (Terumo Aortic) Hospital Care Solutions Division Life Care Solutions Division Pharmaceutical Solutions Division Terumo Blood and Cell Technologies Company (Terumo Blood and Cell Technologies) Sustainability Sustainability News Message from Top Management Sustainability at the Terumo Group Creating a Diverse and Inclusive Workplace Reducing Environmental Footprint Serving Our Communities Report Library GRI Standards Index Technology Basic Information Research and Development Production and Supply Intellectual Property Investors Management Policy Management Policy Top Management Message Business Risks Disclaimer IR Policy IR Library Financial Statements Presentations Terumo Reports IR Events IR Inquiries Financial Highlights Shareholders & Stock Shareholders Meeting Stock Information Shareholder Return Credit Ratings and Corporate Bond Analyst Coverage Articles of Incorporation Site Quote Terms and Conditions of Use Privacy Policy Social Media Policy
Top
Top